I just now took a quick look at http://www.archdaily.com/447862/substances-of-concern-why-material-transparency-matters/#!. This article was written by Rand Ekman, AIA, LEED Fellow, the Director of Sustainability at Cannon Design. At first glance, this would seem to be a very commendable effort to encourage transparency across the construction industry.
I do, however, share the concerns of the other posters about design firms requesting (or “demanding”) such information without the firms’ having the expertise to evaluate the potential impact such information. I consider myself to be a realtively educated person, but my degrees in fine arts, architecture, and business together with a course in high school chemestry (based on about 50-year-old information) does not equip me for any more than the most basic evaluation related to product performance, much less long-term health care considerations. For me to review such information and render any sort of opinion about whether or not the product is “safe” would be an exercise in arrogance and hubris beyond any Greek tragedy.
I do believe in basic transparency; I want to know if the product is wood or plastic or wood composite; I want to know if it burns, and if the composition compromises its application and finish. I am not, however, qualified to review the information to speculate how it might act or react in 20 months or 20 years or whether such action/reaction might be harmful to anyone at that time.
There is a relatively long list of substances (some “natural” like asbestos and some synthetic like thalodimide) which were initially thought to be benovelent, but which turned out to be tragically dangerous. The big problem was that at some point, people became aware that there were problems and chose to conceal that from the public. I can see architects with PHDs tucked away in project files trying to explain to a group of attorneys why they had the information and chose to not act on it in some way to protect the public health and safety.
Merely requiring this information be published does nothing to prevent a bad product from being used if the standard of care at the time was to use the product or does it?